Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 47 for:    Open Studies | "Emergency Medical Services"
Previous Study | Return to List | Next Study

PECARN Emergency Care Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Children's Hospital of Philadelphia
Sponsor:
Collaborator:
Agency for Healthcare Research and Quality (AHRQ)
Information provided by (Responsible Party):
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT01657344
First received: August 2, 2012
Last updated: November 10, 2016
Last verified: November 2016
  Purpose
The objectives of this study are to: develop an emergency care visit registry for pediatric patients for Quality Improvement purposes and to support future research; to use the emergency care visit registry to collect stakeholder-prioritized emergency care performance improvement measures for important pediatric medical and trauma conditions at the level of the ED and individual clinical; and report emergency care performance improvement measures to individual ED clinicians and sites, and measure subsequent changes in quality performance. The hypothesis is that by providing this type of information to individual clinicians will result in improved performance and decreased variability (variation) of care for an individual clinician, between different clinicians, and eventually between hospital sites.

Condition
Pediatric Emergency Care

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Improving the Quality of Pediatric Emergency Care Using an Electronic Medical Record Registry and Clinician Feedback

Resource links provided by NLM:


Further study details as provided by Children's Hospital of Philadelphia:

Primary Outcome Measures:
  • Change in quality performance measures of emergency care clinicians. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
    Emergency care performance improvement measures will be reported to individual emergency department clinicians and sites, and subsequent changes in quality performance will be measured.


Secondary Outcome Measures:
  • Develop an emergency care visit registry for pediatric patients for Quality Improvement purposes and to support future research. [ Time Frame: 36 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 1300300
Study Start Date: January 2011
Estimated Study Completion Date: June 2017
Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts
ED Patients
All patients (age 0-18 regardless of race, ethnicity, or gender and of diagnosis or chronic health condition) who are registered in the ED in the calendar year of 2011 and during a 24 month study period between 2012 and 2015.
ED Practitioners
All licensed independent practitioners who practice in the ED.

  Eligibility

Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Study subjects are all patients (0-18 regardless of race, ethnicity, or gender and of diagnosis or chronic health condition) who are registered to the ED in calendar year of 2011 and during a 36 month study period between 2012 and 2016; all licensed independent practitioners who practice in the ED will also be study subjects.
Criteria

Inclusion Criteria:

  • All patients (0-18) who registered in the ED during 2011 and during a 36 month study period between 2012 and 2016
  • All licensed independent practitioners in the ED during 2011 and during a 36 month study period between 2012 and 2016

Exclusion Criteria:

  • Greater than 18 years of age for ED patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01657344

Contacts
Contact: Elizabeth R Alpern, MD, MSCE ealpern@luriechildrens.org
Contact: Marlena Kittick, MPH 267-426-7931 kittick@email.chop.edu

Locations
United States, Colorado
The Children's Hospital of Colorado Recruiting
Aurora, Colorado, United States, 80045
Contact: Lalit Bajaj, MD, MPH    303-724-2551    lalit.bajaj@childrenscolorado.org   
Sub-Investigator: Lalit Bajaj, MD, MPH         
United States, District of Columbia
Children's National Medical Center Recruiting
Washington, District of Columbia, United States, 20010
Contact: James Chamberlain, MD    202-476-3253    jchamber@childrensnational.org   
Sub-Investigator: James Chamberlain, MD         
United States, Ohio
Cincinnati Children's Hospital Medical Center Recruiting
Cincinnati, Ohio, United States, 45229
Contact: Evaline Alessandrini, MD, MSCE    513-803-2046    Evaline.Alessandrini@cchmc.org   
Sub-Investigator: Evaline Alessandrini, MD, MSCE         
United States, Pennsylvania
The Children's Hospital of Philadelphia Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Robert Grundmeier, MD    267-426-6746    grundmeier@email.chop.edu   
Contact: Marlena Kittick, MPH    267-426-7931    kittick@email.chop.edu   
Principal Investigator: Robert Grundmeier, MD         
United States, Utah
Data Coordinating Center Recruiting
Salt Lake City, Utah, United States, 84158
Contact: Mike Dean, MD, MBA    801-587-7572    Mike.dean@hsc.utah.edu   
Sub-Investigator: Mike Dean, MD, MBA         
Sponsors and Collaborators
Children's Hospital of Philadelphia
Agency for Healthcare Research and Quality (AHRQ)
Investigators
Principal Investigator: Elizabeth R Alpern, MD Lurie Children's Hospital of Chicago
  More Information

Responsible Party: Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier: NCT01657344     History of Changes
Other Study ID Numbers: 12-009177  R01HS020270-01A1 
Study First Received: August 2, 2012
Last Updated: November 10, 2016
Health Authority: United States: Institutional Review Board
Individual Participant Data  
Plan to Share IPD: Yes
Plan Description: When the study is completed, the data coordinating center (DCC) will prepare a distributable database in compliance with Federal requirements.This database will be de-identified sufficiently that it will not be subject to Federal regulations nor the Health Insurance Portability and Accountability Act (HIPAA).There is provision to destroy identifiers before integrating patient data into the registry. Investigators will destroy the master list after 3 years after completion of the research.

Additional relevant MeSH terms:
Emergencies
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on December 02, 2016